Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD

被引:23
|
作者
Boixeda, Ramon [1 ,4 ]
Bacca, Sandra [1 ,4 ]
Elias, Lorena [1 ]
Anton Capdevila, Josep [1 ,4 ]
Vila, Xavier [2 ]
Mauri, Montserrat [1 ]
Almirall, Jordi [3 ]
机构
[1] Consorci Sanitari Maresme, Hosp Mataro, Serv Med Interna, Barcelona, Spain
[2] Consorci Sanitari Maresme, Hosp Mataro, Unidad Neumol, Barcelona, Spain
[3] CIBERES, Consorci Sanitari Maresme, Hosp Mataro, Unidad Cuidados Intensivos, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2014年 / 50卷 / 12期
关键词
Chronic obstructive pulmonary disease; Respiratory infection; Acute exacerbation; Pneumonia; Hospitalization; COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; RISK;
D O I
10.1016/j.arbres.2014.02.001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Pneumonia is considered an independent entity in chronic obstructive pulmonary disease (COPD), to be distinguished from an infectious exacerbation of COPD. The aim of this study was to analyze the clinical characteristics and progress of the exacerbation of COPD (ECOPD) compared to pneumonia in COPD (PCOPD) patients requiring hospitalization. Patients and methods: Prospective, longitudinal, observational cohort study including 124 COPD patients requiring hospital admission for lower respiratory tract infection. Patients were categorized according to presence of ECOPD (n = 104) or PCOPD (n = 20), depending on presence of consolidation on X-ray. Demographic, clinical, laboratory, microbiological and progress variables were collected. Results: Patients with ECOPD showed more severe respiratory disease according to the degree of obstruction (P<.01) and need for oxygen therapy (P<.05). PCOPD patients showed increased presence of fever (P<.05), lower blood pressure (P<.001), more laboratory abnormalities (P<.05; leukocytosis, elevated CRP, low serum albumin) and increased presence of crepitus (P<.01). Microbiological diagnosis was achieved in 30.8% of cases of ECOPD and 35% of PCOPD; sputum culture yielded the highest percentage of positive results, predominantly Pseudomonas aeruginosa. Regarding the progress of the episode, no differences were found in hospital stay, need for ICU or mechanical ventilation. Conclusions: Our data confirm clinical and analytical differences between ECOPD and PCOPD in patients who require hospital admission, while there were no differences in subsequent progress. (C) 2013 SEPAR. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:514 / 520
页数:7
相关论文
共 50 条
  • [41] Pseudomonas spp and antibiotics in exacerbation of chronic obstructive pulmonary disease (COPD)
    Beghi, G
    Pasargiklian, I
    Mascheroni, E
    Boilini, G
    Scarazatti, E
    Lusco, G
    JOURNAL OF CHEMOTHERAPY, 1995, 7 : 163 - 164
  • [42] Descriptive analysis of patients admitted due to COPD exacerbation (COPDE) and COPD-pneumonia
    Munoz Ramirez, Isabel
    Marin Andreu, Alfonso
    Espana Dominguez, Carolina
    Morales Gonzalez, Maria
    Vazquez Gandullo, Eva
    Arnedillo Munoz, Aurelio
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [43] NOCARDIA OTITIDISCAVIARUM: A CAUSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATION
    Bakeer, Mohammad
    Chinnappan, Justine
    Rode, Geeta D.
    AL-Handola, Rami
    CHEST, 2023, 164 (04) : 1384A - 1385A
  • [44] Chronic Obstructive Pulmonary Disease (COPD)
    Lareau, Suzanne C.
    Fahy, Bonnie
    Meek, Paula
    Wang, Angela
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (01)
  • [45] COPD ASSESSMENT TEST (CAT) AS A PREDICTOR FOR MORTALITY AND READMISSION FOLLOWING HOSPITALISATION FOR ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Samuel, S.
    Wood-Baker, R.
    Gibson, P.
    Yang, I
    Hutchinson, A.
    Sajkov, D.
    Mcdonald, V
    RESPIROLOGY, 2016, 21 : 143 - 143
  • [46] Chronic obstructive pulmonary disease (COPD)
    Feetham, Laura
    van Dorn, Aaron
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 18 - 19
  • [47] Chronic Obstructive Pulmonary Disease (COPD)
    Kostikas, Konstantinos
    Hillas, Georgios
    Michaelides, Stylianos A.
    Kontakiotis, Theodore
    Kosmas, Epameinondas N.
    Tzanakis, Nikolaos
    PNEUMON, 2012, 25 : 17 - 23
  • [48] Chronic Obstructive Pulmonary Disease (COPD)
    Gillissen, Adrian
    Rasche, Kurt
    MEDIZINISCHE KLINIK, 2006, 101 (07) : 559 - 570
  • [49] Chronic obstructive pulmonary disease (COPD)
    Pahl, Andreas
    Szelenyi, Istvan
    DRUGS OF THE FUTURE, 2007, 32 (09) : 799 - 807
  • [50] Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
    Ilievska, Daniela Buklioska
    Minov, Jordan
    Mickovski, Ivana
    Kamchevska, Nade Kochovska
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58